Nuvectis Pharma, Inc. (NVCT)
Nuvectis Pharma files for a $150 million mixed securities shelf offering, signaling potential for future growth and development. This news comes amidst significant surges in social media engagement and positive sentiment.
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is a biopharmaceutical company focused on developing and deploying advanced technological solutions.
Nuvectis Pharma, Inc. uses the ticker $NVCT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Nuvectis Pharma, Inc. (NVCT) social dominance is up 109.43% from the previous week.
- Nuvectis Pharma, Inc. (NVCT) sentiment is up 252.94% from the previous [--] months.
- Nuvectis Pharma, Inc. (NVCT) engagements is up 105.64% from the previous week.
- Nuvectis Pharma, Inc. (NVCT) posts created is up 115.38% from the previous week.
- Nuvectis Pharma, Inc. Price hit a 52-Week high of $9.50 for the hour
- Nuvectis Pharma, Inc. Price hit an all time of $9.50 for the hour
Price: $8.80
Price 24-Hour Time-Series Raw Data
The current upward price action, reaching a 52-week high, is likely driven by significant surges in social media engagement and positive sentiment, particularly around the anticipated NXP900 drug data and a recent mixed securities shelf offering.
24-Hour: -0.45% 7-Day: -0.91% 30-Day: 3.3%
1-Year High: $9 on 2026-02-09
1-Year Low: $5.70 on 2025-11-05
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Nuvectis Pharma, Inc. (NVCT) is currently AltRank #1,230 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2026-01-24
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +4
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-01-24
1-Year Low: [--] on 2025-04-25
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +106%
[--] Month: [------] +40%
[--] Months: [-------] -38%
[--] Year: [-------] -16%
1-Year High: [------] on 2025-06-20
1-Year Low: [--] on 2025-08-24
Engagements by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [-----]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -3.70%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-05-25
Mentions by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Nuvectis Pharma, Inc. (NVCT) in the last [--] hours which is down 7.30% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -3.60%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-06-05
The most influential creators that mention Nuvectis Pharma, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @DalvinVarnado | [--] | [------] | [--] | [--] |
| @indian20062 | [--] | [--] | [--] | [--] |
| @JD4for4 | [--] | [-----] | [--] | [--] |
| @USA_Trader03 | [--] | [--] | [--] | [--] |
| @EVAJONE38478931 | [--] | [--] | [--] | [--] |
| @Ella55005 | [--] | [--] | [--] | [--] |
| @BentMatild48050 | [--] | [--] | [--] | [--] |
| @Lola_La_Fleur_ | [--] | [--] | [--] | [--] |
| @BillMiller32 | [--] | [-----] | [--] | [--] |
| @tradingsssss | [--] | [-----] | [--] | [--] |
Sentiment: 76%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 76%
Daily Average: 71%
[--] Week: 50% +30%
[--] Month: 60% +29%
[--] Months: 60% -40%
[--] Year: 60% -40%
1-Year High: 100% on 2025-02-20
1-Year Low: 4% on 2026-01-19
Most Supportive Themes:
- Technological Innovation: (40%) Posts highlighting new product developments and research breakthroughs.
- Industry Leadership: (30%) Content showcasing Nova Cadrus Technologies' influence and expertise in the tech sector.
Most Critical Themes:
- Market Competition: (25%) Discussions and analyses comparing Nova Cadrus Technologies with its competitors.
- Regulatory Landscape: (5%) Information and opinions regarding the impact of new regulations on the company's operations.
Social Dominance: 0.00576%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00576%
Daily Average: 0.00374%
[--] Week: 0.011% +0.0058%
[--] Month: 0.0057% -0.014%
[--] Months: 0.0057% +0.004%
[--] Year: 0.0057% +0.001%
1-Year High: 0.03% on 2025-06-29
1-Year Low: 0.0003% on 2025-08-25
Market Dominance: 0.00026287938368515715%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00026287938368515715%
Daily Average: 0%
1-Year High: 0.011% on 2026-02-06
1-Year Low: 0.00026% on 2026-02-16
Market Cap: $232,067,310
Market Cap 24-Hour Time-Series Raw Data
Current Value: $232,067,310
Daily Average: $222,576,351
[--] Week: $232,332,227 +0.61%
[--] Month: $232,067,310 +6.80%
1-Year High: $239,484,986 on 2026-02-09
1-Year Low: $207,736,807 on 2026-01-20
Top Nuvectis Pharma, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NVCT: Nuvectis Pharma files for $150 mln mixed securities shelf offering https://www.briefing.com/in-depth-analysis/Content/ArticleArticleId=IN20260213160622NVCT&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page https://www.briefing.com/in-depth-analysis/Content/ArticleArticleId=IN20260213160622NVCT&utm_campaign=inplay&utm_medium=social&utm_source=twitter&utm_content=view_page"
X Link @Briefingcom 2026-02-13T23:07Z 34.5K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing